로딩 중…
지수 로딩 중…
3billion
394800· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩6,720-4.27%
2026-06-19
Price Chart
3billion-14.61%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 213.85B KRW |
| Revenue | 13.07B KRW |
| Net Income | -763.2M KRW |
| Total Assets | 28.29B KRW |
| Net Assets | 22.47B KRW |
| Employees | 85 |
| Value | |
| P/B | 9.52x |
| P/S | 16.36x |
| FCF Yield | -3.63% |
| Profitability | |
| ROE | -3.40% |
| ROA | -2.70% |
| Op. Margin | -5.78% |
| Revenue Growth | 67.79% |
| Financial Health | |
| Debt Ratio | 125.91% |
| Total Debt | 189.3M KRW |
| FCF | -7.76B KRW |
| Cash | 6.29B KRW |
| Current Ratio | 5.41x |
| Performance | |
| 1Y Return | -14.61% |
| 1M Return | -27.19% |
| From 52W High | -66.57% |
| 1Y MDD | -64.26% |
| Trading | |
| Volume | 170,310 shares |
| Foreign Own. | 13.25% |
| Per Share | |
| EPS | -163 KRW |
| BPS | 707 KRW |
Company Info
3billion was established in 2016 to revolutionize rare disease diagnosis and treatment development using artificial intelligence, listing on KOSDAQ as a technology growth company in 2024. The company offers whole genome and whole exome-based rare disease diagnostic genetic testing services powered by AI genomic interpretation technology. By launching its genetic variant interpretation software 'GEBRA' as SaaS, 3billion is building an AI drug development platform based on accumulated data and expanding its technological competitiveness. 3billion is headquartered in Gangnam-gu, Seoul Metropolitan City.